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Sudan lies within the meningitis belt and meningococcal disease has been one of its 
major problems throughout the twentieth century. Over 12,000 and 55,000 cases were 
recorded in the years 1935 and 1950 respectively; and during the period 1968-1980, 
over forty thousands (40,513) were inflicted with the disease of whom 1,220 have died. 
A collaborative translational research between the University of Khartoum and Uppsala 
University in Sweden managed to document the epidemiology, clinical features and 
complications of childhood acute bacterial meningitis (ABM) in Sudan during both an 
inter-epidemic (endemic) period (1985-1986), and the 1988 serogroup A epidemic; and 
to examine the phenotypic and genetic similarities and differences of Neisseria 
meningitidis strains isolated in Sudan and Sweden. A novel enzyme immunoassay test 
(Pharmacia Meningitis EIA-Test) was evaluated as a potential rapid diagnostic method 
for the detection of Haemophilus influenzae (HI) type b, Neisseria meningitidis (MC) and 
Streptococcus pneumoniae (PNC). The test was found to have good sensitivity (0.86) 
and specificity (0.95) in the inter-epidemic period; and to be adaptable to the field work in 
Sudan during the 1988 MC epidemic. During inter-epidemic (endemic) situations in 
Sudan, >90 % of childhood ABM was caused by one of the three organisms, HI type b, 
MC and PNC. HI accounted for 57% of the cases. The peak incidence (76%) of HI cases 
was in infants (<12 months) similar to the situation in other African countries. The overall 
case fatality ratio was 18.6%. 
Prospective follow-up of survivors for 3-4 years revealed that an additional 43% either 
died or had permanent neurological complications, the most prevalent and persistent of 
which was sensorineural hearing loss recorded in 22% of long term survivors. Post-
meningitic children were found to have significantly lower intelligence quotients (92.3 ± 
13.9) than their sibling controls (100.7 ± 10.2, P=0.029). Features of the large serogroup 
A sulphonamide resistant MC epidemic (February-August 1988) in Khartoum were 
documented. An estimated annual incidence of 1,679/100,000 was recorded at the peak 
of the epidemic. The highest attack rate was in young children <5 years, as in many 
other African countries; nevertheless, a high morbidity was observed in adults (31% of 
the cases > or = 20 years). The clinical features, mortality (6.3%) and short term 
sequelae in  Sudanese children were generally within the framework described for MC 
disease elsewhere.  
Detailed analysis of MC isolates from Sudan and Sweden by characterizing their 
electrophoretic enzyme types, DNA restriction endonuclease pattern and outer 
membrane proteins, revealed that serogroup A MC clone III-1 was responsible of The 
Sudan epidemic in 1988 and has been the dominant serogroup A organism in Sweden 
since 1973. The Sudanese strains isolated prior to the epidemic (1985) were clone IV-1. 
Clone III-1 has caused two global pandemic waves within three decades and clone IV-1 
has been resident in the meningitis belt for 25 years. This collaborative translational 
research paved the way for the successful control of acute bacterial meningitis following 
the introduction of conjugate vaccines. 
